Correction: Yes1 signaling mediates the resistance to Trastuzumab/Lap atinib in breast cancer.

[This corrects the article DOI: 10.1371/journal.pone.0171356.].

Bibliographic Details
Main Author: PLOS ONE Staff
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2017-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5354437?pdf=render